Bluejay Diagnostics, Inc. Proceeds from Notes Payable
Bluejay Diagnostics, Inc. (BJDX) reported Proceeds from Notes Payable of $2.00 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2026-03-06
- Bluejay Diagnostics, Inc. proceeds from notes payable for the quarter ending 2024-12-31 was $0.00.
- Bluejay Diagnostics, Inc. proceeds from notes payable for the quarter ending 2024-09-30 was $0.00.
- Bluejay Diagnostics, Inc. proceeds from notes payable for the quarter ending 2020-12-31 was $0.00.
- Bluejay Diagnostics, Inc. proceeds from notes payable for fiscal 2024 was $2.00M.
- Bluejay Diagnostics, Inc. proceeds from notes payable for fiscal 2020 was $154.00K.
| Period end | Proceeds from Notes Payable 3 month | Proceeds from Notes Payable 6 month | Proceeds from Notes Payable 9 month | Proceeds from Notes Payable 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $0.00 derived: sum of 2 quarters · filed 2026-03-06 | $2.00M 10-K · filed 2026-03-06 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $2.00M 10-Q · filed 2025-11-07 | ||
| 2024-06-30 | $2.00M 10-Q · filed 2025-08-07 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $154.00K 10-K · filed 2022-03-10 | ||
| 2020-09-30 | $154.00K 10-Q · filed 2021-12-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |